Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate.
Chloë GoossensRuben WeckxSarah DerdeSarah Vander PerreInge DeresePaul P Van VeldhovenBart GhesquièreGreet Van den BergheLies LangouchePublished in: Critical care (London, England) (2021)
These findings point to a role for low cholesterol in critical illness-induced muscle weakness and to a protective mechanism-of-action for 3-hydroxybutyrate supplementation.